Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EI90 of ropivacaine + hydromorphone using PIEB in DPE labor analgesia
ChiCTR2400094109Phase 4Not yet recruiting
- Sponsor
- Sichuan Jinxin Xinan Women and Children Hospital
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine and hydromorphone in labor pain (2 arms), sponsored by Sichuan Jinxin Xinan Women and Children Hospital. Primary endpoint: 90% Effective Analgesia Interval of PIEB. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
ropivacainehydromorphone
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2400094109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094109.